WMA Declaration of Helsinki – Ethical Principles f... ...
Drug candidate slows motor neuron disease progress...
NAD⁺ restores memory in Alzheimer's disease models...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Young adults commonly mix cannabis with nicotine and tobacco...
April 06,2026
You finally got a doctor's appointment. Here's how to get th...
April 05,2026
Thick melanoma tumors may be linked to poorer survival than ...
April 04,2026
Study demonstrates how pediatric integrative medicine can be...
April 03,2026
Sodium bicarbonate fails to boost survival in patients with ...
April 02,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Announcement of the 2025 Nobel Prize in ...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
Dr. Fauci among hundreds who've contract...
More News
CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing

CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing

by Mike StobbeA sign with the CDC logo is displayed at the entrance to the agency's headquarters in Atlanta on March 2, 2025. Credit: Miguel Martinez/Atlanta Journal-Constitution via AP, FileThe f
Technology & AI April 07,2026
CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing

CDC pauses dozens of types of lab testing during evaluation and in wake of downsizing

by Mike StobbeA sign with the CDC logo is displayed at the entrance to the agency's headquarters in Atlanta on March 2, 2025. Credit: Miguel Martinez/Atlanta Journal-Constitution via AP, FileThe f
Technology & AI April 07,2026
20,000 lab-grown human retinas reveal how cone photoreceptor cells resist degeneration

20,000 lab-grown human retinas reveal how cone photoreceptor cells resist degeneration

by Institute of Molecular and Clinical Ophthalmology BaselHuman retinal organoid. Photoreceptors are labeled in green and the light sensing compartment is labeled in red. Organoid cell nuclei are labe
Ophthalmology April 07,2026
20,000 lab-grown human retinas reveal how cone photoreceptor cells resist degeneration

20,000 lab-grown human retinas reveal how cone photoreceptor cells resist degeneration

by Institute of Molecular and Clinical Ophthalmology BaselHuman retinal organoid. Photoreceptors are labeled in green and the light sensing compartment is labeled in red. Organoid cell nuclei are labe
Ophthalmology April 07,2026
Therapeutic, nasally delivered DNA vaccine fuses two genes to help fight tuberculosis

Therapeutic, nasally delivered DNA vaccine fuses two genes to help fight tuberculosis

by Michael E. Newman,Johns Hopkins University School of MedicineArtist’s illustration of tuberculosis (TB) bacteria. A new intranasal therapeutic vaccine against TB, developed by Johns Hopkins researc
Public Health & Prevention April 07,2026
Therapeutic, nasally delivered DNA vaccine fuses two genes to help fight tuberculosis

Therapeutic, nasally delivered DNA vaccine fuses two genes to help fight tuberculosis

by Michael E. Newman,Johns Hopkins University School of MedicineArtist’s illustration of tuberculosis (TB) bacteria. A new intranasal therapeutic vaccine against TB, developed by Johns Hopkins researc
Public Health & Prevention April 07,2026
Unraveling the neural circuitry that makes mice attack

Unraveling the neural circuitry that makes mice attack

byUniversity of TsukubaCredit:iScience(2026). DOI: 10.1016/j.isci.2026.115427When defending their territory, male mice typically appear threatening before launching an attack, ensuring that aggression
Neurology April 07,2026
Unraveling the neural circuitry that makes mice attack

Unraveling the neural circuitry that makes mice attack

byUniversity of TsukubaCredit:iScience(2026). DOI: 10.1016/j.isci.2026.115427When defending their territory, male mice typically appear threatening before launching an attack, ensuring that aggression
Neurology April 07,2026
AI scribes linked to modest reductions in electronic health record use and clinical documentation time

AI scribes linked to modest reductions in electronic health record use and clinical documentation time

byMass General BrighamCredit: Unsplash/CC0 Public DomainDocumenting a patient visit in the electronic health record (EHR) is essential to health care delivery, but also a major contributor to clinicia
Technology & AI April 07,2026
AI scribes linked to modest reductions in electronic health record use and clinical documentation time

AI scribes linked to modest reductions in electronic health record use and clinical documentation time

byMass General BrighamCredit: Unsplash/CC0 Public DomainDocumenting a patient visit in the electronic health record (EHR) is essential to health care delivery, but also a major contributor to clinicia
Technology & AI April 07,2026
Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a
Hematology&Oncology April 07,2026
Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a
Hematology&Oncology April 07,2026
WISDOM trial weighs risk-based cancer screening

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based
Hematology&Oncology April 07,2026
WISDOM trial weighs risk-based cancer screening

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based
Hematology&Oncology April 07,2026
Women are three times more likely than men to get severe long COVID: Here's why

Women are three times more likely than men to get severe long COVID: Here's why

by Gillian Rutherford,University of AlbertaGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102449. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00
Family Medicine April 07,2026
Women are three times more likely than men to get severe long COVID: Here's why

Women are three times more likely than men to get severe long COVID: Here's why

by Gillian Rutherford,University of AlbertaGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102449. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00
Family Medicine April 07,2026
Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d
Hematology&Oncology April 06,2026
Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d
Hematology&Oncology April 06,2026
More News
Week’s Top
Podcasts
... Can AI Catch What Doctors Miss? ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com